John A. Lewicki Insider Trading $OMED OncoMed Pharmaceuticals Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John A. Lewicki.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John A. Lewicki. John A. Lewicki is EVP & Chief Scientific Officer in OncoMed Pharmaceuticals Inc ($OMED) and EVP, Research & Development in OncoMed Pharmaceuticals Inc ($OMED) and President in OncoMed Pharmaceuticals Inc ($OMED) and President & CEO in OncoMed Pharmaceuticals Inc ($OMED) and President and CEO in OncoMed Pharmaceuticals Inc ($OMED).
John A. Lewicki in OncoMed Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John A. Lewicki: President and CEO, President & CEO, President, EVP, Research & Development, EVP & Chief Scientific Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 23 2019
$OMED Market Capitalization: $294.51M
$OMED Previous Close: $8.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John A. Lewicki in OncoMed Pharmaceuticals Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2019 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President and CEO | Sell | U | 0.00 | 142,534 | 0 | 0 | 142.5 K to 0 (-100.00 %) |
| Oct 11 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President & CEO | Sell | S | 2.01 | 1,156 | 2,324 | 55,966 | 57.1 K to 56 K (-2.02 %) |
| Oct 10 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President & CEO | Sell | S | 2.13 | 2,296 | 4,888 | 57,122 | 59.4 K to 57.1 K (-3.86 %) |
| Apr 26 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President & CEO | Sell | S | 2.68 | 4,557 | 12,202 | 55,418 | 60 K to 55.4 K (-7.60 %) |
| Mar 19 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President & CEO | Option Exercise | A | 2.98 | 125,000 | 372,500 | 125,000 | |
| Feb 23 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President | Option Exercise | A | 2.23 | 125,000 | 278,750 | 125,000 | |
| Jan 08 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Option Exercise | A | 3.98 | 100,000 | 398,000 | 100,000 | |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Sell | S | 4.24 | 1,202 | 5,099 | 70,412 | 71.6 K to 70.4 K (-1.68 %) |
| Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Sell | S | 4.26 | 46 | 196 | 71,614 | 71.7 K to 71.6 K (-0.06 %) |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Option Exercise | A | 4.36 | 50,000 | 218,000 | 50,000 | |
| Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Grant | A | 0.00 | 25,000 | 0 | 71,660 | 46.7 K to 71.7 K (+53.58 %) |
| Apr 25 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Option Exercise | A | 3.73 | 67,500 | 251,775 | 67,500 | |
| Apr 25 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Grant | A | 0.00 | 22,500 | 0 | 45,437 | 22.9 K to 45.4 K (+98.09 %) |
| Apr 05 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Sell | S | 9.06 | 5,711 | 51,731 | 22,937 | 28.6 K to 22.9 K (-19.94 %) |
| Apr 05 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Sell | S | 8.87 | 43 | 381 | 28,648 | 28.7 K to 28.6 K (-0.15 %) |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Option Exercise | A | 7.66 | 65,000 | 497,900 | 65,000 | |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Option Exercise | M | 1.43 | 9,175 | 13,120 | 0 | |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Sell | S | 7.63 | 9,175 | 70,045 | 31,636 | 40.8 K to 31.6 K (-22.48 %) |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Buy | M | 1.43 | 9,175 | 13,120 | 40,811 | 31.6 K to 40.8 K (+29.00 %) |
| Oct 11 2016 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Grant | A | 0.00 | 12,500 | 0 | 31,636 | 19.1 K to 31.6 K (+65.32 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 21.33 | 1 | 21 | 17,838 | 17.8 K to 17.8 K (-0.01 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 21.56 | 69 | 1,488 | 17,839 | 17.9 K to 17.8 K (-0.39 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 22.30 | 2,092 | 46,653 | 17,908 | 20 K to 17.9 K (-10.46 %) |
| Dec 29 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | A | 21.43 | 70,000 | 1,500,100 | 70,000 | |
| Jun 17 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 3.42 | 2,898 | 9,911 | 134,423 | |
| Jun 17 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 5,602 | 8,011 | 9,175 | |
| Jun 17 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 8,500 | 12,155 | 14,777 | |
| Jun 17 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 25.22 | 8,500 | 214,333 | 20,000 | 28.5 K to 20 K (-29.82 %) |
| Jun 17 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 3.42 | 2,898 | 9,911 | 28,500 | 25.6 K to 28.5 K (+11.32 %) |
| Jun 17 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 5,602 | 8,011 | 25,602 | 20 K to 25.6 K (+28.01 %) |
| Jun 17 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 24.92 | 8,500 | 211,792 | 20,000 | 28.5 K to 20 K (-29.82 %) |
| Jun 17 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 8,500 | 12,155 | 28,500 | 20 K to 28.5 K (+42.50 %) |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 8,500 | 12,155 | 23,277 | |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 8,500 | 12,155 | 31,777 | |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 25.70 | 1,560 | 40,089 | 21,285 | 22.8 K to 21.3 K (-6.83 %) |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 25.29 | 6,940 | 175,515 | 22,845 | 29.8 K to 22.8 K (-23.30 %) |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 8,500 | 12,155 | 29,785 | 21.3 K to 29.8 K (+39.93 %) |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 25.19 | 8,500 | 214,105 | 21,285 | 29.8 K to 21.3 K (-28.54 %) |
| Apr 03 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 8,500 | 12,155 | 29,785 | 21.3 K to 29.8 K (+39.93 %) |
| Feb 04 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 40,277 | |
| Feb 04 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 22.49 | 4,000 | 89,951 | 20,000 | 24 K to 20 K (-16.67 %) |
| Feb 04 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |
| Jan 05 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 44,277 | |
| Jan 05 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 22.79 | 400 | 9,116 | 20,000 | 20.4 K to 20 K (-1.96 %) |
| Jan 05 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 22.03 | 3,600 | 79,293 | 20,400 | 24 K to 20.4 K (-15.00 %) |
| Jan 05 2015 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |
| Dec 22 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | A | 21.18 | 50,000 | 1,059,000 | 50,000 | |
| Dec 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 48,277 | |
| Dec 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 21.19 | 4,000 | 84,752 | 20,000 | 24 K to 20 K (-16.67 %) |
| Dec 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |
| Nov 05 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 52,277 | |
| Nov 05 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Gift | G | 0.00 | 602 | 0 | 83,530 | 82.9 K to 83.5 K (+0.73 %) |
| Nov 05 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 20.45 | 4,000 | 81,818 | 20,000 | 24 K to 20 K (-16.67 %) |
| Nov 05 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |
| Nov 05 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Gift | G | 0.00 | 602 | 0 | 20,000 | 20.6 K to 20 K (-2.92 %) |
| Oct 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 5,809 | 8,307 | 56,277 | |
| Oct 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 20.00 | 5,809 | 116,180 | 20,602 | 26.4 K to 20.6 K (-21.99 %) |
| Oct 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 5,809 | 8,307 | 26,411 | 20.6 K to 26.4 K (+28.20 %) |
| Sep 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 2,191 | 3,133 | 62,086 | |
| Sep 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 20.01 | 2,191 | 43,831 | 20,602 | 22.8 K to 20.6 K (-9.61 %) |
| Sep 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 2,191 | 3,133 | 22,793 | 20.6 K to 22.8 K (+10.63 %) |
| Aug 04 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 64,277 | |
| Aug 04 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 20.98 | 4,000 | 83,912 | 20,000 | 24 K to 20 K (-16.67 %) |
| Aug 04 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |
| Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 68,277 | |
| Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 24.36 | 704 | 17,151 | 20,000 | 20.7 K to 20 K (-3.40 %) |
| Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 23.75 | 3,296 | 78,283 | 20,704 | 24 K to 20.7 K (-13.73 %) |
| Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |
| Jun 17 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 72,277 | |
| Jun 17 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 24.59 | 4,000 | 98,348 | 20,000 | 24 K to 20 K (-16.67 %) |
| Jun 17 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |
| Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Gift | G | 0.00 | 1,792 | 0 | 82,928 | 81.1 K to 82.9 K (+2.21 %) |
| Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Gift | G | 0.00 | 1,792 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
| Mar 12 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Gift | G | 0.00 | 81,136 | 0 | 81,136 | 0 to 81.1 K |
| Mar 12 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Gift | G | 0.00 | 81,136 | 0 | 1,792 | 82.9 K to 1.8 K (-97.84 %) |
| Jul 23 2013 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | C | 0.00 | 5,159 | 0 | 0 | |
| Jul 23 2013 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | C | 0.00 | 3,132 | 0 | 0 | |
| Jul 23 2013 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | C | 0.00 | 5,159 | 0 | 81,136 | 76 K to 81.1 K (+6.79 %) |
| Jul 23 2013 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | C | 0.00 | 3,132 | 0 | 75,977 | 72.8 K to 76 K (+4.30 %) |
| Jul 19 2013 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | A | 17.00 | 14,000 | 238,000 | 14,000 |
Page: 1